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Abstract
Background: A dynamic vasculature is a prerequisite for bone formation where the interaction of bone cells and
endothelial cells is essential for both the development and the healing process of bone. Enhanced understanding
of the specific mediators involved in bone cell and endothelial cell interactions offers new avenues for skeletal
regenerative applications. This study has investigated the osteogenic and angiogenic potential of co-cultures of
human foetal diaphyseal or epiphyseal cells with human umbilical vein endothelial cells (HUVEC) in the presence
and absence of vascular endothelial growth factor (VEGF) supplementation.
Methods: Early osteogenic activities of the co-cultures (±VEGF) were assessed by alkaline phosphatase (ALP)
activity. Osteogenic and angiogenic gene expression was measured using quantitative polymerase chain reaction.
An ex vivo organotypic embryonic chick (E11) femur culture model was used to determine the osteogenic effects
of VEGF as determined using micro-computed tomography (μCT) and Alcian blue/Sirius red histochemistry and
immunocytochemistry for expression of CD31.
Results: ALP activity and gene expression of ALP and Type-1 collagen was enhanced in foetal skeletal/HUVECs
co-cultures. In foetal diaphyseal/HUVECs co-cultures, VEGF reduced the levels of ALP activity and displayed a negligible
effect on von Willebrand factor (vWF) and VEGF gene expression. In contrast, VEGF supplementation was observed to
significantly increase FLT-1 and KDR gene expression in co-cultures with modulation of expression enhanced, compared
to VEGF skeletal monocultures. In the organotypic chick model, addition of VEGF significantly enhanced bone
formation, which coincided with elevated levels of CD31-positive cells in the mid-diaphyseal region of the femurs.
Conclusion: These studies demonstrate a differential skeletal response of early foetal skeletal cells, when co-cultured
with endothelial cells and the potential of co-culture models for bone repair. The differential effect of VEGF
supplementation on markers of angiogenesis and osteogenesis in co-cultures and organ cultures, demonstrate the
importance of the intricate temporal coordination of osteogenic and angiogenic processes during bone formation and
implications therein for effective approaches to bone regenerative therapies.
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Background
Bone formation and repair are highly orchestrated,
temporal coordinated processes involving mechanical,
biochemical, molecular and cellular factors. During en-
dochondral bone formation the emergent bone is formed
from a cartilage template. As the cartilage matures and
remodels, skeletal progenitors form from the incoming
vasculature, and differentiate into osteoblasts, which in
turn form bone on the cartilage template [1]. A func-
tioning microvasculature is thus critical within the bone
regenerative process, providing a supply of oxygen, nu-
trients and cells, and serve as a conduit for the removal
of waste [2]. In the absence of a functional and adequate
vasculature network, tissue necrosis and failure of any
implanted tissue graft will ultimately occur [3, 4].
There is substantial evidence that the interplay be-
tween vascular cells and the cells responsible for bone
formation (osteoblasts, osteoprogenitors and skeletal
stem cells) is critical in the concomitant development of
a functional vasculature and the maintenance of skeletal
homeostasis [5, 6]. Indeed, it has been established that
the enhancement of the osteogenic differentiation of os-
teoblasts is due to the direct contact culture with endo-
thelial cells (EC) [7, 8], resulting in an elevation of
expression of markers such as alkaline phosphatase
(ALP) [9, 10] and type I collagen [11, 12]. Villars and co-
workers reported an increase in ALP activity only in
contact co-cultures of human umbilical vein endothelial
cells (HUVEC) and human bone marrow stromal cells
(HBMSC). The gap junction protein Connexin43 (CX43)
expressed by both cell types [13–16] was observed to be
critical in the coupling of this osteogenic induced mech-
anism. In contrast, indirect co-culture resulted in de-
creased ALP activity and increased proliferation of
HBMSCs in HUVEC-conditioned media. Moreover, the
addition of vascular endothelial growth factor (VEGF) to
the culture media had no significant effect on the co-
cultures although a negative effect on ALP activity of
HBMSC was observed [9].
Kaigler et al. demonstrated that EC-mediated bone
morphogenic protein-2 (BMP-2) signalling enhanced
HBMSC osteogenic differentiation in co-culture in
vitro, with a significant increase in ALP activity. Fur-
thermore, transplantation of co-cultured cells on a
polymer scaffold increased bone formation in vivo;
however, there was no significant angiogenic response
compared to monoculture cell controls [17]. Interest-
ingly, Bouletreau et al. also observed up-regulation of
BMP-2 gene and protein expression by endothelial
cells, in response to hypoxia and/or VEGF; however,
the authors noted that inhibition of VEGF translation
did not abolish this effect, implicating hypoxia as play-
ing a key role in the increase in BMP-2 [18]. Recently,
Leszcynska and colleagues demonstrated that direct co-
cultures of HBMSCs and HUVECs at distinct ratios
(50:50, 80:20 and 20:80) enhanced ALP activity, signifi-
cantly up-regulating ALP and collagen type 1 gene ex-
pression and cell proliferation [12]. Zhang et al.
reported that co-cultures of HUVECs and MG-63 oste-
oblasts result in the proliferation of osteoblasts and el-
evated levels of collagen type 1 and ALP, and a
reduction of osteocalcin, which is a late marker of
osteogenesis, close to the mineralisation stage, was also
observed [7].
VEGF, a 40-kDa mitogen, has been shown to be a cen-
tral component in bone development and a prerequisite
for a number of processes in bone fracture repair and
bone formation. Ferrara and colleagues elegantly demon-
strated that the most common isoform VEGF165 and its
receptors R1 (FLT-1) and R2 (KDR) are essential for
endothelial proliferation, migration, vascular permeabil-
ity and endothelial cell survival [19]. Chondrogenesis
and osteogenesis during endochondral bone formation
are dynamically linked with the invasion of vasculature,
and VEGF is observed in the hypertrophic chondrocytes
as the primary ossification centers form and mineralisa-
tion proceeds [20, 21]. VEGF and its receptors have
been shown to interact with endothelial cells during
bone development as early as E8.5 in mice embryos,
with VEGF-R1 (Flt-1) and R2 (Flk-1) knock-outs result-
ing in lethality due to failure of structural formation of
a vascular network [22, 23]. However, less well-known
is the interaction of VEGF with skeletal cells such as
chondrocytes, osteoblasts and osteoclasts [24]. Street
and co-workers demonstrated that a slow release
model of VEGF enhances both endochondral and
intramembranous ossification whilst inhibition results
in a decrease in blood vessel formation, bone forma-
tion and callus mineralization [25]. Inhibition of VEGF
is also associated with an expansion of the hyper-
trophic zone and disruption of trabecular bone forma-
tion in developing mice femurs [20], however, it has
been suggested that the fracture hematoma formed
during injury but not during development has potent
angiogenic activity through VEGF signalling [26]. Stud-
ies on the temporal release of VEGF and dual release
of VEGF and BMP-2 from poly-lactic acid scaffolds
seeded with HBMC in vivo have shown a significant in-
crease in endochondral bone formation and skeletal
defect repair [27, 28].
The current study has examined the interaction of
key cell types present during human skeletal develop-
ment and how exogenous added VEGF affects these
processes. Understanding these mechanisms where
vascular cells and osteoprogenitor cells combine to
induce bone formation, repair and vasculogenesis will
enhance approaches to cell-based skeletal tissue
engineering.
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Methods
Materials
Foetal calf serum (FCS) was purchased from Invitrogen
Life Technologies, Scotland. Penicillin/streptomycin
(Pen/Strep), trypsin/EDTA, minimal essential medium,
α-modification (α-MEM) and Medium 199 and other
tissue culture reagents were purchased from Lonza, Not-
tingham, UK. Endothelial cell growth supplement
(ECGS) was obtained from Promocell, Heidelberg,
Germany. Alkaline phosphatase staining reagents and
assay kit and other cell culture reagents were purchased
from Sigma Aldrich, Poole, Dorset, UK. Human VEGF-
165 was purchased from PeproTech EC Ltd., London,
UK. Collagenase B was purchased from Roche Diagnos-
tic Ltd., Lewes, East Sussex, UK. Tissue culture plastics
were purchased from Greiner BioOne, okGloucestershire,
UK.
Foetal femur diaphyseal and epiphyseal cell isolation and
culture
Human foetal tissues were obtained from female patients
undergoing termination of pregnancy in line with the
Polkinghome Report guidelines. Informed consent was
given in writing by the patients, under ethical approval
from Southampton & South West Hampshire Local Re-
search Ethics Committee (LREC 296/100). Femurs from
approximately 8 weeks post conception (foot length 5.0–
5.5 mm) were isolated from foetuses. The surrounding
skeletal connective and muscle tissues were removed
from the foetal femur sample and both epiphyses were
separated from the diaphysis by micro-dissection (trans-
verse incision through the metaphysis region at either
end of the bone collar, when present). Proximal and dis-
tal epiphyses were combined in each sample and care-
fully cut into small segments, as was the diaphysis. The
dissected femur parts were submerged in collagenase B
in a 6-well plate and incubated overnight at 37 °C, 5 %
CO2. The cell suspension was centrifuged and re-
suspended in α-MEM, supplemented with 10 % FCS and
1 % Pen/Strep. The cells were cultured in a monolayer
under standard conditions until 95 % confluency was
reached. Culture medium was changed every 3–4 days.
Human umbilical vein endothelial cell isolation and culture
Human umbilical cords were obtained, following signed
consent, from healthy mothers after normal, full-term
deliveries at the Princess Anne Hospital, Southampton
under ethical approval from Southampton & South West
Hampshire Local Research Ethics Committee (LREC 05/
Q1702/102). HUVEC were isolated and cultured as de-
scribed by Jaffe et al. (1973) [29] with minor modifica-
tions. The umbilical cord veins were flushed through
with 1 × PBS to remove cord blood and drained of any
excess fluid. Cords were then infused with a 5 mg/ml
solution of collagenase B (Roche) and incubated for
1 hour at room temperature to detach the endothelial
lining cells. The collagenase solution was drained from
the umbilical cord using a 20 ml syringe and collected in
a sterile 50 ml conical tube. The cell suspension was di-
luted by adding equal amounts of 1 × PBS and then cen-
trifuged at 1000 g for 5 minutes. The HUVEC cell pellet
was re-suspended and cultured in endothelial culture
medium (Medium 199 (Lonza) supplemented with 1 %
Pen/Strep, 10 % FCS, ECGM 0.4 % (v/v) (Promocell) and
replenished every 3–4 days.
Two-dimensional co-culture of diaphyseal/epiphyseal
foetal femur cells and human umbilical vein endothelial
cells
Foetal femur cells derived from the diaphyseal, epiphyseal
regions and endothelial cells were trypsinised prior to con-
fluency, washed and re-suspended in 10 ml of a 1:1 mix-
ture of endothelial culture medium (supplemented with
ECGS) and alpha-medium, both supplemented with 10 %
FCS and 1 % Pen/Strep. A cell count was performed using
a haemocytometer and cell suspension volumes contain-
ing 2 × 105 cells were transferred to universal tubes for the
different cell types: 8 ml of the above culture medium
mixture was added to each tube as basal medium and sup-
plemented with or without 100 ng/ml VEGF. The cell sus-
pension of each tube was transferred at 2 ml/well to a 6-
well tissue culture plate and cultured at 37 °C, 5 % CO2
for 7 days. A media change was performed on day 4.
Biochemical analysis
Alkaline phosphatase staining
Alkaline phosphatase activity from cells in mono- and
co-cultures in 6-well tissue culture plates was measured
by washing in 1 × PBS, fixing cells in 90 % ethanol and
applying 600 μl of 4 % (v/v) Naphthol AS-MX phosphate
(Sigma) and 0.0024 % fast violet B-salt (Sigma) mixed in
distilled water. Cells were incubated at 37 °C for up to
40 minutes, when the reaction was stopped and the im-
ages captured and processed using a Zeiss Axiovert 200
inverted microscope, software version 4.7.
Alkaline phosphatase activity
Alkaline phosphatase activity was measured using a col-
orimetric assay (P-nitrophenol phosphate (pNPP) turn-
over) measuring absorbance at 410 nm on an ELx800
spectrophotometer. In brief, 10 μl of cell lysate was
transferred to a 96-well clear assay plate and made up to
100 ul with 90 μl phosphatase substrate (Sigma) in
1.5 M alkaline buffer solution (Sigma). The cell lysate
was incubated at 37 °C for up to 40 minutes and termi-
nated with 100 μl of 1 M sodium hydroxide prior to
reading on the spectrophotometer. Results were expressed
as nmol pNPP/h.
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Molecular biology
Quantitative RT-PCR analysis
RNA isolation was performed using Qiagen RNeasy Mini
Kit. Cultured cells were washed twice in 1 × PBS and lysed
using RLT buffer (Qiagen). One volume of 70 % Ethanol
was added in order to precipitate the RNA. This was then
transferred to an RNeasy spin column and centrifuged to
separate the RNA. RNA was eluted from the spin column
with RNase-free H2O. The SuperScript® VILO™ (Invitro-
gen 11754050) cDNA synthesis kit was used for cDNA
synthesis according to the manufacturer’s protocol; 5X
VILO™ reaction mix and 10X SuperScript© enzyme were
added to the appropriate amount of RNA and incubated
at 25 °C for 10 minutes followed by 2 h at 42 °C. The reac-
tion was terminated at 85 °C for 5 minutes. The cDNA
sample was diluted 1:2 with RNase free H2O and stored at
–20 °C or used immediately for quantitative RT-PCR
analysis.
Quantitative PCR was performed using Power SYBR-
Green PCR master mix (Invitrogen Life Technology).
The reaction was made up with 1 μl of cDNA sample,
12.5 μl of SYBR-Green master mix, 6.5 μl RNase free
H2O, 2.5 μl of reverse and forward primers for the gene
of interest (Table 1). The final reaction mix was trans-
ferred to a 96-well plate, centrifuged briefly and analysed
using Applied Biosystems® 7500 Real Time PCR system
(Life Technology). The resulting data were analyzed
using AB7500 SDS Software, version 2.0.5 programme.
Cycle threshold (Ct) values for each sample were nor-
malised to the housekeeping gene β-Actin. Fold-
expression levels of each target gene were calculated
using the ΔΔ Ct method. Sample variation in combining
averages of relative gene expression produced strong de-
viations. In order to overcome this sample variability, we
analysed repeat data for relative expression from three
patients individually for all genes investigated.
Organotypic embryonic chick femur culture
Femurs were dissected from 11-day-old chick embryos
(Gallus domesticus). Soft tissue, including adherent mus-
cles and ligaments, were carefully removed while pre-
serving the periosteum. Non-cultured control femurs
were immediately fixed in 4 % paraformaldehyde (PFA).
The dissected femurs for organotypic cultures were
washed in 1 × PBS and placed in organotypic culture as
previously described [30, 31] . The bones were trans-
ferred to 6-well plates and positioned on 0.40-μm filter
well inserts at the interface between the air and the basal
culture medium (1 ml of basal tissue culture medium
(TCM) consisting of α-MEM, penicillin (100 U/ml),
streptomycin (100 μg/ml), and ascorbic acid 2-
phosphate (100 μM) (Sigma). Cultures were maintained
in basal medium for 24 h at 37 °C in humidified air
with 5 % CO2. The organotypic cultures were then in-
cubated in different culture conditions - basal TCM
(1 ml); basal TCM + 25 ng/ml VEGF (1 ml) and basal
TCM + 100 ng/ml VEGF (1 ml). Culture media was
changed daily for the duration of the experiment
(10 days) (n = 4 femurs per group). After 10 days cul-
ture, the femurs were washed in 1 × PBS (×3) and fixed
overnight in 4 % PFA.
Micro-computed tomography (μCT)
Quantitative 3D analysis of the fixed chick femurs was
performed using a SkyScan 1176 scanning system (Bruker
μCT, Kontich). Samples were scanned at 18 μm resolution
and reconstructed using NRecon software interface
(v.1.6.4.6, Bruker μCT, Kontich). Reconstructed femurs
were analysed using CT Analyser (v.1.13.2.1+, Bruker
μCT, Kontich). Bone volume (BV), tissue volume (TV),
bone volume/tissue volume (BV/TV) ratio; bone surface/
volume ratio (BS/BV), trabecular number (Tb.N), trabecu-
lar spacing (Tb.Sp) and trabecular thickness (Tb.Th) of
the femurs were calculated (n = 4).
Histology and immunohistochemistry
Histology
Once analysed by μCT, samples were dehydrated
through a series of methanol washes (50 %, 90 % and
100 % in dH2O) and incubated in Histo-Clear (National
Diagnostics). Following incubation in paraffin wax for
1 h at 60 °C, samples were embedded in wax blocks
using an automated Shandon Citadel 2000. Consecutive
7-μm-thick sections were cut throughout the depth of
Table 1 Quantitative polymerase chain reaction primers of osteogenic and angiogenic genes, with housekeeping gene β-Actin
Gene Abbreviations Forward 5'-3' Reverse 3'-5’
Human β-Actin Actin ggcatcctcaccctgaagta aggtgtggtgccagattttc
Human alkaline phosphatase ALP ggaactcctgacccttgacc tcctgttcagctcgtactgc
Human type I collagen Col1 gagtgctgtcccgtctgc tttcttggtcggtgggtg
Human von Willebrand factor vWF gttcgtcctggaaggatcgg cactgacacctgagtgagac
Human VEGF165 VEGF tatgcggatcaaacctcacca cacagggatttttcttgtcttgct
Human Flt-1 (VEGF-R1) Flt-1 aaaggcacccagcacatcat ttcccccctgcattgga
Human KDR (VEGF-R2) KDR attcctcccccgcatca gctcgttggcgcactctt
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the central femur. Mounted sections were rehydrated
through Histo-Clear, graded methanols and dH2O before
staining with Weigert’s haematoxylin and Alcian blue/
Sirius red (A/S), indicators of proteoglycan and collagen
deposition respectively. Sections were then dehydrated
and mounted with DPX (distyrene plasticizer xylene)
before imaging with an Olympus BX-51/22 dotSlide
digital virtual microscope using OlyVIA 2.1 software
(Olympus Soft Imaging Solutions, GmBH).
Immunohistochemistry
Mounted sections were rehydrated through Histo-Clear,
graded methanol and dH2O washes before incubation
with 3 % hydrogen peroxide to quench endogenous per-
oxidase activity. Sections were then treated with hyal-
uronidase and 0.5 % Triton-X for cell permeabilisation
before incubation with blocking buffer (1 % BSA in PBS)
for 1 h at room temperature. Primary antibody solution
(CD31 (PECAM1) Source BioScience LifeSciences, 1:100
with blocking buffer) was then added and slides were left
overnight at 4 °C. Biotin-conjugated secondary antibody
solution (1:100 with blocking buffer) was added for 1 h
at room temperature. Biotinylated sections were then in-
cubated with ExtrAvidin peroxidase (1 h at room
temperature) and subsequently 3-amino-9-ethylcarba-
zole (AEC) substrate solution (maximum 10 minutes at
room temperature) to visualise positive labelling by gen-
eration of brown immune complex reaction product.
Light green and Alcian blue were used as counterstains,
and slides were mounted with Hydromount (Fisher
Scientific, UK). Negative controls included primary anti-
body exclusion. Images were captured with an Olympus
BX-51/22 dotSlide digital virtual microscope using
OlyVIA 2.1 software (Olympus Soft Imaging Solutions,
GmBH) as described above.
Statistical analysis
Quantitative polymerase chain reaction data and alkaline
phosphatase biochemical activity were analysed using
one-way analysis of variance (ANOVA) with Tukey-
Kramer multiple comparison post-hoc test, and con-
firmed using two-tailed unpaired Student’s t test on
GraphPad Prism 6 software. P values ≤0.05 were consid-
ered significant. Statistical analysis of μCT data were cal-
culated as mean ± standard deviation. Differences among
groups were determined by one-way ANOVA with post-
hoc Dunnett’s test and statistical differences were con-
sidered to be significant if p ≤0.05.
Results
Alkaline phosphatase activity and gene expression in
co-cultures of EC and FFDSCs
Cell populations derived from the diaphysis of the foetal
femur in mono-/co-culture demonstrated enhanced ALP
activity in contrast to epiphyseal foetal femur-derived
cells or HUVEC after 7 days of culture (Fig. 1). En-
hanced expression of ALP was observed in co-cultures
of diaphyseal and epiphyseal cells together with HUVEC
in contrast to mono-culture populations alone. The
addition of VEGF (100 ng/ml) to the cultures reduced
the levels of ALP expression (Fig. 1).
Diaphyseal cells (D) in basal mono-cultures displayed
enhanced ALP activity, compared to epiphyseal cells (E)
in basal mono-cultures, while HUVECs displayed negli-
gible ALP activity (Fig. 2a, c). In basal co-cultures ALP
activity was significantly increased in epiphyseal co-
cultures (CoE) (Fig. 2c), with approximately three-fold
increase in all three patient samples, compared to diaphy-
seal co-cultures (CoD) (approximately one- to three-fold)
in two out of three patient samples (Fig. 2a). Diaphyseal
co-cultures also showed a significant approximately two-
fold reduction in ALP activity over respective monocul-
tures, in one out of the three patient samples. The
addition of VEGF to the cultures resulted in a significant
diminution in ALP activity in diaphyseal co-cultures com-
pared to respective basal co-cultures in all three samples
(Fig. 2b). In the epiphyseal co-cultures, no significant
change was observed in responses to VEGF (Fig. 2d).
ALP gene expression in basal CoD had a varied re-
sponse to co-culture conditions between patient samples
(Fig. 3a), however basal CoE had consistently signifi-
cantly increased gene expression in all three experiments
(range approximately 3-fold to 40-fold difference)
(Fig. 3c). The addition of VEGF to the cultures resulted
in suppression of ALP gene expression in CoD (Fig. 3b),
but in the CoE there was no effect on ALP expression
apart from one patient sample, in which it was signifi-
cantly reduced (Fig. 3d).
Type 1 collagen, VEGF and vWF gene expression in
co-cultures of EC and FFDSCs
Type I collagen expression was significantly increased
predominantly in basal diaphyseal co-cultures in con-
trast to monoculture groups (Fig. 4a). Similarly, in CoD
treated with VEGF, a significant increase in type I colla-
gen was observed (Fig. 4b). Basal CoE also showed a sig-
nificant increase in type I collagen expression in two of
three samples (Fig. 4c). In contrast, the addition of
VEGF produced a variable response in the three patient
samples analysed (Fig. 4d). Analysis of relative gene ex-
pression of von Willebrand factor (vWF) (Additional file
1) and VEGF indicated variable expression of both in re-
sponse to co-culture conditions in basal media and to
the addition of VEGF (Additional file 2). Responses to
VEGF in co-cultures of both CoD and CoE were not sig-
nificant. No significant changes in VEGF gene expression
in mono- or co-cultures with or without additional
VEGF were observed.
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VEGF-receptor FLT-1 and KDR gene expression in
co-cultures of EC and FFDSCs
The addition of VEGF to HUVEC cultures signifi-
cantly increased expression levels of FLT-1 (R1). In
contrast in basal media of both monocultures D and
E FLT-1 (R1) expression was found to be extremely
low (Fig. 5a, c), which was not further enhanced with
VEGF supplementation to the monocultures (Fig. 5b/
d). However, in the co-cultures, significant increase in
receptor expression (D/CoD =maximum approximately
80-fold; E/CoE = maximum approximately 116-fold) in
basal and approximately 2-fold to 3-fold further in-
crease with the addition of VEGF in both CoD and
CoE, compared to their respective co-cultures in basal
medium was observed. Overall, the mRNA levels of
FLT-1 (R1) in co-cultures displayed a greater increase
when VEGF was added to the media compared to cul-
tures in basal media; however, sample variability pre-
cluded any conclusion as to whether CoD or CoE
displayed a greater response.
Fig. 1 Alkaline phosphatase staining at day 7. Representative images of basal monoculture controls (a, b, c) and monocultures supplemented
with 100 ng/ml vascular endothelial growth factor (VEGF) (d, e, f) of human umbilical vein endothelial cells (HUVEC) (a, d), foetal diaphyseal cells
(b, e) and foetal epiphyseal cells (c, f); co-cultures of diaphyseal/HUVEC in basal media (g) and supplemented with 100 ng VEGF (i); co-cultures of
epiphyseal/HUVEC in basal media (h) and supplemented with 100 ng VEGF (j). Scale bar 100 μm
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The levels of KDR (R2) gene expression in basal HUVEC
was significantly elevated (2-fold to 15-fold increase) when
cultured with VEGF (Fig. 6b, d). In contrast to HUVEC
expression of the KDR (R2) gene, negligible receptor ex-
pression was observed in the D and E monocultures
(Fig. 6a–d). However, in the co-cultures we found that re-
ceptor expression compared to the D and E monocultures
were elevated with a 4-fold to 6-fold increase in CoD and
a 1.5-fold to 116-fold increase in CoE, respectively, with
the addition of VEGF to the cultures (Fig. 6b, d).
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Fig. 2 Alkaline phosphatase (ALP) activity. ALP activity measured in nmol P-nitrophenol phosphate (pNNP)/ml h-1 mono-/co-cultures supplemented
with and without vascular endothelial growth factor (VEGF) (100 ng/ml). Assays from three separate patient samples. a Basal diaphyseal/human
umbilical vein endothelial cell (HUVEC) mono-/co-cultures; b diaphyseal/HUVEC mono-/co-cultures supplemented with VEGF; c basal epiphyseal/
HUVEC mono-/co-cultures; d epiphyseal/HUVEC mono-/co-cultures supplemented with VEGF. Results are expressed as mean ± SD: *p <0.05, **p <0.01,
***p <0.001. CoD diaphyseal co-culture, CoE epiphyseal co-culture
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The osteogenic effects of VEGF on organotypic
embryonic E11 chick femur cultures
In organotypic chick femur cultures supplementation of
VEGF (25 ng/ml) displayed negligible osteogenesis com-
pared to basal cultured femurs. In contrast, addition of
VEGF at 100 ng/ml, significantly elevated the osteogenic
effect on organotypic cultures of D11 embryonic chick
femurs after 10 days in culture (Fig. 7a, b), evidenced by
the increase in structural bone parameters (BV, Tb.Th
and Tb.No and reduced Tb.Sp) compared to basal cul-
tured femurs.
Histological analysis of the organotypic chick femur
cultures depicted similar outcomes to the μCT results.
The mid-diaphyseal region of the control basal femur
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group was predominantly composed of cartilage (evi-
denced by Alcian blue staining) with discrete collage-
nous bone matrix (evidenced by Sirius red staining) in
the periosteal regions. In contrast, the collagen staining
observed was much denser in the VEGF groups with
concomitant reduction of the cartilage region. Interest-
ingly, in the VEGF (100 ng/ml) group, the whole of the
mid-diaphyseal region appeared to be made up of
trabecular-like bone (Sirius red) with no evidence of car-
tilage staining, apart from the peripheral, metaphyseal
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regions (Fig. 8a–c). Furthermore, the addition of VEGF
to the organotypic culture of embryonic chick femurs at
both concentrations elevated the numbers of CD31-
positive cells in the diaphyseal region of the femur com-
pared to the basal cultured femurs (Fig. 8d–f ).
Discussion
The current study has examined the interactive pro-
cesses of the three major cell types (diaphyseal/epiphys-
eal femur cells and endothelial cells) present during
early foetal femoral development to further understand
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the concomitant angiogenesis and osteogenesis that oc-
curs in skeletal development, and is recapitulated in
fracture repair. Initially, we demonstrated that the early
osteogenic differentiation marker ALP was elevated
when foetal femur-derived stem cells (FFDSC) from both
the diaphyseal and epiphyseal regions were co-cultured
in direct contact with endothelial cells. This corre-
sponded to previous reports that adult osteoprogenitor
cells in direct culture with HUVECs induce an in-
crease in ALP [9, 11].
Interestingly, in our studies, we found that the supple-
mentation of the potent angiogenic growth factor VEGF
to these co-cultures resulted in differing responses be-
tween the diaphyseal and epiphyseal FFDSCs. VEGF sup-
plementation reduced the levels of ALP in the diaphyseal/
HUVEC co-culture group, whereas in contrast, there was
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a variable response in the epiphyseal/HUVEC group com-
pared to both co-culture groups without VEGF supple-
mentation. Within the co-cultures, an increase in the gene
expression of type 1 collagen compared to monocultures
was observed, however, the addition of VEGF had a negli-
gible effect. Similarly, there was no increase in the gene
expression of VEGF and vWF in the co-cultures. Upon
analysis of the VEGF receptor genes 1 (FLT-1) and 2
(KDR), we found significant differences in the co-cultures
with further increases in the receptor expression upon
addition of VEGF, with receptor 2 being more sensitive to
VEGF stimulation compared to receptor 1.
Within the skeletal environment, vascular cells play a
fundamental role in modulating the osteogenic progres-
sion of the developing bone and in the temporal cascade
of bone defect repair. Human foetal skeletal populations
contain primitive progenitor/bone stem cell populations,
which maintain a high degree of proliferation and plasti-
city potential [32]. The cells from the epiphyseal and
diaphyseal regions of the foetal femur provide a prede-
termined chondrogenic and osteogenic population of
cells respectively, hence, being ideal for investigations
into skeletogenesis [33, 34]. We hypothesised that co-
integration of vascular endothelial cells with these multi-
potent foetal femur cells could modulate osteogenesis
and to a degree, angiogenesis, in line with endochondral
bone formation during bone development and repair.
The response of the cells in contact co-cultures of
early human skeletal and endothelial cells appear to be
dependent on the differentiation state of the cells
present in culture. Although the diaphyseal and epiphys-
eal cells are predominantly associated with osteogenic
and chondrogenic phenotypes, respectively, these popu-
lations are not homogenous. While the diaphyseal and
epiphyseal cells are of an immature phenotype and of
limited development, the populations represent a devel-
opmental continuum with immature osteoprogenitors
and chondroprogenitors, that also contains mature
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Fig. 7 The effect of vascular endothelial growth factor (VEGF) (25 ng/ml and 100 ng/ml) on organotypic cultures of embryonic femurs (E11).
a Micro computed tomography images. b Micro computed tomography analysis of bone volume (BV), bone surface/bone volume (BS/BV), bone
volume/tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.No) and trabecular spacing (Tb.Sp) (n = 4 femurs per group).
Significant differences compared to non-cultured femurs, *p ≤0.05, **p ≤0.01, ***p ≤0.001. Significant difference between basal and VEGF cultured
femurs represent mean ± SD: #p ≤0.05, ##p ≤0.01, ###p ≤0.001
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chondrocyte sub-populations. This was reflected in the
variability and fluctuation of expression observed in
osteogenic markers ALP and type I collagen and the lack
of change in angiogenic factors vWF and VEGF across
the differing patient samples within the study. Addition-
ally, it is important to note, patient-to-patient variation
will contribute to the variability in the results observed
(indicated by the observed differences in ALP activity
and ALP gene expression) and that gene expression and
protein expression are not always correlated. This vari-
ation was also reflected in increased levels of ALP in one
patient, displaying an enhanced osteogenic phenotype. It
would appear that cells isolated from these femoral re-
gions at this stage of differentiation are not responsive
to the angiogenic stimulation of VEGF, evidenced by low
levels of mRNA. Low VEGF mRNA expression may add-
itionally reflect modulation through its cognate recep-
tors on surrounding cells, as reviewed by Marini et al.
[35]. It is possible that the cells themselves may produce
and release VEGF into the media, resulting in variability
of expression; however, Grellier et. al. previously mea-
sured VEGF release by osteoprogenitor cells and
HUVECs in co- and mono-cultures but only detected
the VEGF in the supernatant of osteoprogenitors after
48 h. Similarly, Leszczynska et al. examined VEGF re-
lease by HUVECs and human bone marrow-derived
cells in various co-culture ratios over 4 and 7 days.
The authors noted significant amounts of VEGF in
the human bone marrow cells. Thus, given the rela-
tively high concentration of VEGF (100 ng/ml) in the
current study, the possible paracrine release by the
cells would have contributed only minimally to the
overall effect observed [12, 36].
Ramasamy et al. have postulated that bone formation
is governed by a specialised angiogenic mode, implicat-
ing the Notch signalling pathway as the angiogenic path-
way acting directly on osteoblasts. Disruption of Notch
signalling resulted in impaired blood vessel formation,
reduced bone formation and chondrocyte differentiation.
Furthermore, Noggin (BMP-antagonist) restored these
vascular and skeletal disruptions [37]. In addition, the
authors identified endothelial cells with high expression
of Endomucin (Emcn) and CD31 residing in the distal
arches of metaphyseal vessels of long bones, with highly
expressed VEGF receptors 1, 2 and 3 in the bone.
Hellstrom et al., demonstrated that distinct types of
endothelial cells are involved in angiogenesis and can
modulate their phenotype according to the stages of
neovascularisation and VEGF availability. De-activation
and activation of the Dll-4 (Delta-like-ligand 4) and
Notch 1 pathway, respectively, was observed to switch
the differential behaviour of the endothelial cells on and
off resulting in a highly effective mechanism in func-
tional and optimised blood vessel formation [38]. As
previously established, the exposure and sequestration of
VEGF is in turn orchestrated mainly by VEGF receptors
Fig. 8 Histological analysis of the effect of vascular endothelial growth factor (VEGF) (25 ng/ml and 100 ng/ml) on organotypic cultures of
embryonic femurs (E11). a–c Alcian blue/Sirius red staining; d–f CD31 immunohistochemical staining. CD31-positive cells within the diaphyseal
trabecular bone indicated by arrows, negative control inset) (n = 4 femurs per group). Scale bar 100 μm
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1 and 2, and similar to our findings any differentiation
and change in phenotype of the ECs cells can have an ef-
fect on how these cells respond to contact with osteo-
blastic cells and/or exogenous VEGF.
Osteoblasts express VEGF receptors [39, 40], and contact
with HUVECs in co-culture may trigger the inhibition of
VEGF receptors in order to prepare the tissue for bone
healing and possibly inhibit bone resorption at this differen-
tial stage, which would be enhanced by VEGF [25, 40, 41].
In HUVEC monocultures, high expression levels of KDR
(R2) and FLT-1 (R1) were observed indicating the ECs were
in a highly proliferative state [42], which in turn was
increased by the addition of VEGF to the HUVECs. In
contrast, HUVECs in contact with osteoblastic cells in basal
media, displayed reduced proliferation in preparation for
differentiation towards mature ECs. However, the addition
of VEGF switched the balance back again from differenti-
ation towards proliferation, increasing VEGF receptor
mRNA. Recent work has shown the importance of endo-
thelial cells ability to differentiate into skeletal cells by
endothelial-mesenchymal transition [43], and their subse-
quent role in heterotopic ossification. However, it cannot
be dismissed that mesenchymal skeletal progenitor cells
may have the capacity to differentiate into endothelial cells
as evidenced by studies demonstrating Rho/MRTF-A sig-
nalling pathway as a critical factor in VEGF differentiation
of mesenchymal stem cells (MSC) to endothelial cells and
that the combined effect of matrix elasticity and VEGF can
also modulate MSC to the endothelial phenotype, respect-
ively [44, 45]. Analysis of gene expression of the relevant
osteogenic and angiogenic markers in each of the separate
HUVEC and foetal skeletal cell populations will indicate
the modulating effects occurring in this co-culture system.
However, as this is a contact bound co-culture effect, we
were concerned that mechanical separation of the individ-
ual cell types would disrupt the very connections under
analysis in the contact co-cultures. Elegant studies by
Grellier et al. separated the HUVEC portion from their
co-culture system using magnetic cell sorting, however
techniques such as magnetic-activated cell sorting
(MACS) and fluorescence-activated cell sorting (FACS)
typically are not 100 % efficient, therefore caution is re-
quired in evaluating data from contact-co-culture isolated
cells [36]. Furthermore, we have not examined cell separ-
ation from our co-cultures, as foetal femur cells derived
from foetal femoral tissue are not a homogenous popula-
tion of cells (chondrogenic, osteogenic and endothelial
populations as well as skeletal and endothelial progenitor
and stem sub-populations) and thus, a concern was the in-
ability to generate 100 % verifiable efficient separation be-
tween our cell types.
In an organotypic cultured femur model, we found
that embryonic chick femurs at E11 displayed significant
levels of new bone formation when supplemented with a
high dose of VEGF. No expression of the endothelial cell
marker CD31 was observed in non-cultured femurs
(data not shown), and in basal cultured femurs, positive
CD31 cells were found to be residing in the periosteal
region of the femur. In marked contrast, VEGF addition
resulted in an increase in CD31-positive cells in the
mid-diaphyseal region of these cultured femurs, with mi-
gration into the newly formed trabecular bone cavities,
which correlated with an increase in osteogenesis. In
bone development VEGF is highly expressed in the
hypertrophic chondrocytes and inhibition of VEGF by
administering a soluble chimeric VEGF receptor, signifi-
cantly reduces blood vessel invasion into the hyper-
trophic region of long bones resulting in expansion of
the growth plate and a reduction in trabecular bone for-
mation in 24-day-old mice [20]. The current results indi-
cate that at the early stages of the osteogenic process in
the femur, VEGF plays a critical part in the developing
femur with the potential migration/differentiation of
endothelial phenotype cells in the mid-diaphyseal region
of bone. Interestingly, the location of these progenitor
cells undergoing differentiation due to VEGF, is unclear.
Thus, fate tracing of these population of cells (for ex-
ample, whether or not they are of pericyte origin), will
inform additional approaches to recruit these specialised
cells for future therapies to regenerate bone. These stud-
ies confirm the importance of direct cell contact as a
crucial prerequisite in early osteogenesis. Further modu-
lation of the co-culture system to deliver a facile tem-
poral response to enable osteogenesis and angiogenesis
and our understanding of the molecular interaction of
vascular cells and associated osteoprogenitors will be
crucial for future bone regenerative therapies.
Conclusion
This study has demonstrated that contact co-cultures of
foetal femur-derived stem cells and human umbilical
vein endothelial cells enhance mechanisms of osteogen-
esis and angiogenesis in bone, evident in a significant in-
crease in early osteogenic markers ALP and Col1 and a
significant modulation of VEGF receptor activity in co-
cultures that did not result in modulation of VEGF gene
expression. We observed intricate differential responses
from cells originating from the diaphysis and epiphysis
of the foetal femur. Diaphyseal co-cultures triggered a
stronger response of Col1 gene expression with and
without addition of VEGF than the epiphyseal fractions;
however epiphyseal co-cultures displayed greater ALP
activity compared to diaphyseal co-culture groups. Sup-
plementation of VEGF decreased the enhancing effect of
co-cultures in the diaphyseal co-culture group in vitro;
however, in an ex vivo model of chick femoral defect, a
significant increase in bone formation with the addition
of VEGF and stimulation of CD31-positive cells within
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the primary ossification centre, was demonstrated. This
study shows great future therapeutic potential in using
co-culture models for fracture repair.
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Additional file 1: von Willebrand factor relative gene expression.
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